Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs placebo for sedation during radiofrequency catheter ablation of atrial fibrillation
2010-023020-24Phase 4Terminated
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Dexmedetomidine (Precedex) with Placebo (2 arms). Primary endpoint: Sedation level caused by dexmedetomidine. Started Oct 2010; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2010-023020-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023020-24.